British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

…, T Raine, PA Hendy, PJ Smith, JK Limdi, BH Hayee… - Gut, 2019 - gut.bmj.com
Ulcerative colitis and Crohn’s disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

[HTML][HTML] Magnification endoscopy in esophageal squamous cell carcinoma: a review of the intrapapillary capillary loop classification

…, H Sato, H Minami, EG Santi, BH Hayee… - … Publication of the …, 2015 - ncbi.nlm.nih.gov
Recent developments in image-enhancement technology have enabled clear visualization
of the microvascular structure of the esophageal mucosa. In particular, intrapapillary capillary …

Endoscopy's current carbon footprint

K Siau, BH Hayee, S Gayam - Techniques and Innovations in …, 2021 - Elsevier
Each year, over 18 million endoscopy procedures are performed in the United States (US)
alone. Endoscopy is the third highest generator of waste in healthcare, a sector with …

Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease

AM Smith, FZ Rahman, BH Hayee, SJ Graham… - Journal of Experimental …, 2009 - rupress.org
The cause of Crohn's disease (CD) remains poorly understood. Counterintuitively, these
patients possess an impaired acute inflammatory response, which could result in delayed …

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

…, R Hansen, A Hart, AB Hawthorne, BH Hayee… - Gut, 2020 - gut.bmj.com
The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally.
Early insights have been made possible by rapid sharing of data from China and Italy. In …

[HTML][HTML] Reducing the environmental footprint of gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of …

…, P Burga, L Donnelly, A Eickhoff, BH Hayee… - …, 2022 - thieme-connect.com
Climate change and the destruction of ecosystems by human activities are among the
greatest challenges of the 21st century and require urgent action. Health care activities …

[HTML][HTML] Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study

…, H Sato, C Phalanusitthepha, BH Hayee… - … publication of the …, 2014 - ncbi.nlm.nih.gov
Background In our previous case report of circumferential mucosal resection for short-segment
Barrett’s esophagus with high-grade dysplasia, symptoms of gastro-esophageal reflux …

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 …

…, M Lukas, JP Gisbert, G d'Haens, B Hayee… - The lancet …, 2022 - thelancet.com
Background Etrolizumab is a gut-targeted anti-β7 integrin monoclonal antibody. In a previous
phase 2 induction study, etrolizumab significantly improved clinical remission versus …

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

…, A Geccherle, ML Annunziata, B Hayee… - The Lancet …, 2022 - thelancet.com
Background A treat-to-target strategy, in which strictly defined treatment targets facilitate
decision making in clinical practice, is advocated as an optimised management approach for …

PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting …

…, P Bhandari, S Danese, JG Ferraz, BH Hayee… - Gut, 2022 - gut.bmj.com
Histological remission is evolving as an important treatment target in UC. We aimed to develop
a simple histological index, aligned to endoscopy, correlated with clinical outcomes, and …